Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition. Sometimes, autoimmune cells will get activated due to molecular imitation between pathological antigens and self. Animal autoimmune diseases mostly arise from prolonged sustained immune responses against self. This mechanism is responsible for the breakdown of animal autoimmune tolerance. Animal autoimmune diseases mainly induced by triggering lymphocytes. In some cases because of autoimmune diseases, the animal loses complete or part of the targeted tissue. In other cases, animal tissues are damaged chronically by an autoimmune reaction, which results in inhibition of the tissue. Once if the autoimmune reaction started, it leads to the impairment of the targeted tissue. The reasons for animal autoimmune diseases are obscure; it appears that malfunction occurs in recognition, whereas animal body fails to differentiate foreign and self. Trauma, viral infections, and vaccination are most common reasons for autoimmune diseases in animals. Most common type of autoimmune diseases in animals are systemic lupus erythematosus, autoimmune myasthenia gravis, autoimmune hemolytic anemia, diabetes mellitus, and thrombocytopenia. Treatment mainly includes conventional steroids at high doses.
Scope of the Report:This report studies the Animal Autoimmune Diseases Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Animal Autoimmune Diseases Testing market by product type and applications/end industries.
Increasing incidence of autoimmune diseases of animal requires a continuous diagnosis and treatment because they pose a potential threat to the life of the animal. In most of the cases, autoimmune diseases can't treat. So proper care and diagnosis in early stages are required to save the life of the animals. Due to technology transfer, diagnostics test become more precise, convenient, and easy than the conventional diagnostic test which gives result faster and detailed. It results in the complete understanding of autoimmune diseases by veterinary doctors. It makes easy to control the autoimmune diseases by the animal owners. A range of diagnostic tests is used to diagnosis the autoimmune diseases. It gives a new opportunity to the animal autoimmune disease testing manufacturers. The government is also taking initiates to protect the companion animals from autoimmune diseases. All these factors drive the burgeoning growth of the animal autoimmune diseases testing the market.Ê
Gaps in epidemiological knowledge on certain autoimmune diseases and pitfalls in identifying animal antigen/immunogenic structure are acts as the restraint in the growth of the animal autoimmune diseases testing the market.
The global Animal Autoimmune Diseases Testing market is valued at xx million USD in 2020 and is expected to reach xx million USD by the end of 2026, growing at a CAGR of xx% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Animal Autoimmune Diseases Testing.
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
Market Segment by Companies, this report covers Alvedia
VMRD
IVD Technologies
Nova Tec Immundiagnostica
Immunolab
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Anti-Nuclear Antibody Testing
Coombs Testing
Lupus Erythematosus Cell Test
Immunofluorescent Antibody Testing
Coagulation Tests
Others
Market Segment by Applications, can be divided into Companion Animals
Live Stocks Animals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
